vs
FirstCash Holdings, Inc.（FCFS）与Pediatrix Medical Group, Inc.（MD）财务数据对比。点击上方公司名可切换其他公司
FirstCash Holdings, Inc.的季度营收约是Pediatrix Medical Group, Inc.的1.0倍（$501.3M vs $493.8M），FirstCash Holdings, Inc.净利率更高（20.8% vs 6.8%，领先14.0%），FirstCash Holdings, Inc.同比增速更快（21.2% vs -1.7%），过去两年FirstCash Holdings, Inc.的营收复合增速更高（16.9% vs -0.1%）
FirstCash Holdings, Inc.是总部位于美国得克萨斯州沃斯堡的典当企业，在美国及拉丁美洲多地运营线下典当零售门店，为纳斯达克证券交易所公开上市企业，在美洲典当服务领域拥有成熟的业务布局与完善的运营网络。
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
FCFS vs MD — 直观对比
营收规模更大
FCFS
是对方的1.0倍
$493.8M
营收增速更快
FCFS
高出22.9%
-1.7%
净利率更高
FCFS
高出14.0%
6.8%
两年增速更快
FCFS
近两年复合增速
-0.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $501.3M | $493.8M |
| 净利润 | $104.2M | $33.7M |
| 毛利率 | — | — |
| 营业利润率 | 28.5% | 9.9% |
| 净利率 | 20.8% | 6.8% |
| 营收同比 | 21.2% | -1.7% |
| 净利润同比 | 24.7% | 10.5% |
| 每股收益（稀释后） | $2.35 | $0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FCFSMD
| Q4 25 | $501.3M | $493.8M | ||
| Q3 25 | $411.0M | $492.9M | ||
| Q2 25 | $385.1M | $468.8M | ||
| Q1 25 | $371.1M | $458.4M | ||
| Q4 24 | $413.7M | $502.4M | ||
| Q3 24 | $363.1M | $511.2M | ||
| Q2 24 | $363.5M | $504.3M | ||
| Q1 24 | $366.8M | $495.1M |
净利润FCFSMD
| Q4 25 | $104.2M | $33.7M | ||
| Q3 25 | $82.8M | $71.7M | ||
| Q2 25 | $59.8M | $39.3M | ||
| Q1 25 | $83.6M | $20.7M | ||
| Q4 24 | $83.5M | $30.5M | ||
| Q3 24 | $64.8M | $19.4M | ||
| Q2 24 | $49.1M | $-153.0M | ||
| Q1 24 | $61.4M | $4.0M |
营业利润率FCFSMD
| Q4 25 | 28.5% | 9.9% | ||
| Q3 25 | 27.4% | 13.8% | ||
| Q2 25 | 21.1% | 12.8% | ||
| Q1 25 | 30.0% | 7.0% | ||
| Q4 24 | 26.5% | 7.8% | ||
| Q3 24 | 23.5% | 6.6% | ||
| Q2 24 | 18.2% | -31.3% | ||
| Q1 24 | 22.3% | 3.2% |
净利率FCFSMD
| Q4 25 | 20.8% | 6.8% | ||
| Q3 25 | 20.1% | 14.5% | ||
| Q2 25 | 15.5% | 8.4% | ||
| Q1 25 | 22.5% | 4.5% | ||
| Q4 24 | 20.2% | 6.1% | ||
| Q3 24 | 17.9% | 3.8% | ||
| Q2 24 | 13.5% | -30.3% | ||
| Q1 24 | 16.7% | 0.8% |
每股收益（稀释后）FCFSMD
| Q4 25 | $2.35 | $0.40 | ||
| Q3 25 | $1.86 | $0.84 | ||
| Q2 25 | $1.34 | $0.46 | ||
| Q1 25 | $1.87 | $0.24 | ||
| Q4 24 | $1.86 | $0.37 | ||
| Q3 24 | $1.44 | $0.23 | ||
| Q2 24 | $1.08 | $-1.84 | ||
| Q1 24 | $1.35 | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $125.2M | $375.2M |
| 总债务越低越好 | $2.2B | $570.5M |
| 股东权益账面价值 | $2.3B | $865.9M |
| 总资产 | $5.3B | $2.2B |
| 负债/权益比越低杠杆越低 | 0.98× | 0.66× |
8季度趋势，按日历期对齐
现金及短期投资FCFSMD
| Q4 25 | $125.2M | $375.2M | ||
| Q3 25 | $130.2M | $340.1M | ||
| Q2 25 | $101.5M | $224.7M | ||
| Q1 25 | $146.0M | $99.0M | ||
| Q4 24 | $175.1M | $229.9M | ||
| Q3 24 | $106.3M | $103.8M | ||
| Q2 24 | $113.7M | $19.4M | ||
| Q1 24 | $135.1M | $8.0M |
总债务FCFSMD
| Q4 25 | $2.2B | $570.5M | ||
| Q3 25 | $2.2B | $577.2M | ||
| Q2 25 | $1.7B | $583.9M | ||
| Q1 25 | $1.7B | $590.5M | ||
| Q4 24 | $1.7B | $597.1M | ||
| Q3 24 | $1.7B | — | ||
| Q2 24 | $1.7B | — | ||
| Q1 24 | $1.5B | — |
股东权益FCFSMD
| Q4 25 | $2.3B | $865.9M | ||
| Q3 25 | $2.2B | $890.7M | ||
| Q2 25 | $2.1B | $833.8M | ||
| Q1 25 | $2.1B | $789.2M | ||
| Q4 24 | $2.1B | $764.9M | ||
| Q3 24 | $2.0B | $732.5M | ||
| Q2 24 | $2.0B | $706.5M | ||
| Q1 24 | $2.0B | $856.2M |
总资产FCFSMD
| Q4 25 | $5.3B | $2.2B | ||
| Q3 25 | $5.2B | $2.2B | ||
| Q2 25 | $4.5B | $2.1B | ||
| Q1 25 | $4.4B | $2.0B | ||
| Q4 24 | $4.5B | $2.2B | ||
| Q3 24 | $4.4B | $2.1B | ||
| Q2 24 | $4.3B | $2.0B | ||
| Q1 24 | $4.2B | $2.2B |
负债/权益比FCFSMD
| Q4 25 | 0.98× | 0.66× | ||
| Q3 25 | 1.01× | 0.65× | ||
| Q2 25 | 0.79× | 0.70× | ||
| Q1 25 | 0.83× | 0.75× | ||
| Q4 24 | 0.85× | 0.78× | ||
| Q3 24 | 0.87× | — | ||
| Q2 24 | 0.85× | — | ||
| Q1 24 | 0.75× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $206.6M | $114.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 1.98× | 3.39× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FCFSMD
| Q4 25 | $206.6M | $114.1M | ||
| Q3 25 | $135.8M | $137.3M | ||
| Q2 25 | $116.9M | $137.2M | ||
| Q1 25 | $126.6M | $-117.5M | ||
| Q4 24 | $198.1M | $133.0M | ||
| Q3 24 | $113.1M | $91.8M | ||
| Q2 24 | $106.2M | $107.0M | ||
| Q1 24 | $122.5M | $-125.2M |
现金转化率FCFSMD
| Q4 25 | 1.98× | 3.39× | ||
| Q3 25 | 1.64× | 1.91× | ||
| Q2 25 | 1.95× | 3.49× | ||
| Q1 25 | 1.51× | -5.66× | ||
| Q4 24 | 2.37× | 4.36× | ||
| Q3 24 | 1.74× | 4.72× | ||
| Q2 24 | 2.16× | — | ||
| Q1 24 | 2.00× | -31.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FCFS
| US Pawn Segment | $292.2M | 58% |
| Retail POS Payment Solutions | $209.8M | 42% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
